Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer

NCT07589517 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
48
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Beijing Biotech